EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer

EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer

Abstract Background This study aims to clarify the prognostic role of epidermal growth factor receptor (EGFR) mutations in plasma of non-small cell lung cancer (NSCLC) for resistance to tyrosine kinase inhibitor (TKI), in correlation with clinical characteristics. A total of 94 Adenocarcinoma, clini...

Full description

Bibliographic Details
Main Authors: Thang Thanh Phan, Bich-Thu Tran, Son Truong Nguyen, Toan Trong Ho, Hang Thuy Nguyen, Vu Thuong Le, Anh Tuan Le
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Clinical and Translational Medicine
Subjects:
EGFR plasma mutation test
Secondary T790M
cfDNA
NSCLC
Online Access:http://link.springer.com/article/10.1186/s40169-019-0219-8

Internet

http://link.springer.com/article/10.1186/s40169-019-0219-8

Similar Items